Citizens Jmp Begins Coverage on RXO (NYSE:RXO)

Investment analysts at Citizens Jmp initiated coverage on shares of RXO (NYSE:RXO) in a research note issued on Wednesday, MarketBeat.com reports. The firm set a “market perform” rating on the stock.

Several other research analysts have also issued reports on the company. Susquehanna raised their target price on RXO from $18.00 to $20.00 and gave the stock a “negative” rating in a research report on Tuesday. TD Cowen upped their price target on RXO from $14.00 to $21.00 and gave the company a “hold” rating in a research report on Friday, May 8th. Zacks Research raised RXO from a “strong sell” rating to a “hold” rating in a research note on Monday, April 6th. Stifel Nicolaus raised their price objective on RXO from $22.00 to $30.00 and gave the stock a “buy” rating in a research report on Monday. Finally, The Goldman Sachs Group reaffirmed a “neutral” rating and issued a $18.00 price objective on shares of RXO in a research note on Friday, May 8th. Four investment analysts have rated the stock with a Buy rating, twelve have assigned a Hold rating and three have given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $23.57.

RXO Price Performance

RXO stock opened at $28.52 on Wednesday. The company has a fifty day moving average price of $25.54 and a 200-day moving average price of $18.99. The company has a market capitalization of $4.70 billion, a P/E ratio of -46.76 and a beta of 2.03. RXO has a 52-week low of $10.43 and a 52-week high of $29.86. The company has a debt-to-equity ratio of 0.28, a quick ratio of 1.27 and a current ratio of 1.27.

RXO (NYSE:RXO) last issued its quarterly earnings results on Thursday, May 7th. The company reported ($0.09) EPS for the quarter, hitting analysts’ consensus estimates of ($0.09). RXO had a negative net margin of 1.83% and a negative return on equity of 1.16%. The company had revenue of $1.43 billion for the quarter, compared to analyst estimates of $1.34 billion. During the same quarter in the previous year, the business earned ($0.03) earnings per share. RXO’s revenue was down .6% compared to the same quarter last year. As a group, equities analysts expect that RXO will post 0.07 EPS for the current year.

Hedge Funds Weigh In On RXO

Hedge funds and other institutional investors have recently bought and sold shares of the company. Orbis Allan Gray Ltd grew its holdings in RXO by 6.5% during the 4th quarter. Orbis Allan Gray Ltd now owns 34,677,755 shares of the company’s stock worth $438,327,000 after acquiring an additional 2,104,597 shares during the period. Franklin Resources Inc. raised its position in shares of RXO by 91.2% in the 3rd quarter. Franklin Resources Inc. now owns 2,328,843 shares of the company’s stock worth $35,818,000 after acquiring an additional 1,110,530 shares in the last quarter. Vaughan Nelson Investment Management L.P. acquired a new position in shares of RXO in the 4th quarter valued at about $11,224,000. Wellington Management Group LLP lifted its stake in shares of RXO by 7.9% in the 3rd quarter. Wellington Management Group LLP now owns 9,998,681 shares of the company’s stock valued at $153,780,000 after purchasing an additional 735,810 shares during the period. Finally, Kennedy Capital Management LLC acquired a new position in shares of RXO in the 4th quarter valued at about $9,098,000. Institutional investors and hedge funds own 92.73% of the company’s stock.

Key RXO News

Here are the key news stories impacting RXO this week:

• Positive Sentiment: Truist Financial raised its price target on RXO from $26 to $30 and reiterated a buy rating, signaling confidence in further upside from current levels. Analyst update via Benzinga
• Positive Sentiment: BMO Capital Markets initiated coverage with an outperform rating and a $35 price target, one of the more bullish calls in the latest batch. BMO Capital Markets initiation via Benzinga
• Neutral Sentiment: Goldman Sachs raised its target from $18 to $20 but kept a neutral rating, suggesting valuation may be more limited despite the higher target. Goldman Sachs update via Benzinga
• Neutral Sentiment: Citizens JMP initiated coverage with a market perform rating, indicating a more cautious stance and no strong conviction either way. Citizens JMP coverage via Zacks
• Neutral Sentiment: Susquehanna also lifted its price target to $20, but that still sits well below the current trading level, implying limited near-term upside from their perspective. Susquehanna update

RXO Company Profile

RXO Inc (NYSE: RXO) is a leading asset-light provider of digital freight brokerage and managed transportation solutions. The company leverages a proprietary technology platform to connect shippers with a network of third-party carriers, enabling optimized route planning, real-time shipment tracking, and dynamic pricing. RXO’s end-to-end service model spans full truckload, less-than-truckload (LTL), intermodal and cross-border freight movements, designed to improve efficiency and reduce transportation costs for its customers.

Operating primarily across North America, RXO serves a diverse base of shippers in industries ranging from retail and consumer goods to manufacturing and automotive.